LB Pharma Shares Climb 15% After Raising $285 Million in IPO (1)

Sept. 11, 2025, 8:12 PM UTC

LB Pharmaceuticals Inc. shares closed 15% higher in their trading debut after the biotech raised $285 million in an upsized initial public offering.

Shares in the company ended at $17.30 each on Thursday. The company sold 19 million shares for $15 each, according to a statement Wednesday, after offering 16.7 million shares in a range of $14 to $16 apiece.

The trading gives the New York-based company a market value of about $348 million, based on the outstanding shares listed in its filings.

LB Pharma’s IPO ended well oversubscribed, according to people familiar with the matter. It attracted anchor orders ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.